Partnership Services

Pharmaceutical development and manufacturing, structured around the product.

Jean Vichar supports contract manufacturing and development programs across solid dosage forms, metered dose inhalers and nasal sprays, with dry powder inhaler expertise available through Lirok Pharma.

REF. JV-CDMO-001ENGAGEMENT MODEL

CMO when the product is established. CDMO when development work remains.

The right model depends on the maturity of the product, the quality of the available technical package and the work required before routine commercial production.

For an established product, Jean Vichar can assess the existing process, analytical methods, material specifications, packaging configuration and supply expectations before defining a contract manufacturing pathway. Where formulation, process adaptation, device integration, scale-up or registration support is still required, the engagement can include development activities in addition to manufacturing.

Every opportunity begins with technical and quality review. Scope, responsibilities, documentation, timelines and decision points are agreed before execution begins.

REF. JV-SCOPE-002SERVICE SCOPE

CMO

Contract manufacturing

For products with an established formulation, process and technical package that require transfer into an appropriate manufacturing platform.

  • Technical feasibility and gap review
  • Technology and analytical method transfer
  • Engineering and validation batches
  • Commercial batch manufacture
  • Primary and secondary packaging coordination
  • Ongoing supply and change management
CDMO

Development and manufacturing

For products that require additional technical work before a stable, transferable and commercially viable process can be established.

  • Formulation and process assessment
  • Development planning and risk identification
  • Scale-up and process adaptation
  • Device and packaging compatibility review
  • Registration-document support
  • Transition to commercial manufacture

REF. JV-JOURNEY-003PARTNERSHIP JOURNEY

Eight connected stages, with responsibilities defined at each step.

01

Discovery

Clarify the product, intended market, technical package, target volumes and commercial objectives.

02

Formulation

Review or develop the composition, dosage form, delivery system and critical product attributes.

03

Scale-up

Adapt the process to available equipment and establish appropriate operating ranges and controls.

04

Validation

Plan the evidence required to demonstrate repeatable performance of methods, cleaning and production processes.

05

Registration

Support the manufacturing and technical information required for the agreed registration pathway.

06

Commercial Manufacturing

Execute approved batch records and controls within the established quality framework.

07

Packaging

Coordinate components, artwork, coding and pack configuration for the intended market.

08

Distribution

Where appropriate, coordinate domestic delivery through Ti-One and the wider pharmaceutical ecosystem.

REF. JV-TRANSFER-004TECHNOLOGY TRANSFER

Transfer is a controlled exchange of knowledge, not simply a handover of documents.

A successful transfer requires enough information to understand why the process works, where it is sensitive and how quality is demonstrated. Jean Vichar reviews the available development history, master formula, process description, material attributes, analytical methods, stability information, packaging system and previous manufacturing experience.

Open questions are converted into a documented work plan. Trials, engineering batches and validation activities are then used to confirm that the process is suitable for the selected platform.

Technical package reviewEvaluate completeness, consistency and transfer readiness.
Risk and gap assessmentIdentify missing information and critical transfer risks early.
Method and process transferAlign procedures with the receiving site and equipment.
Commercial readinessConfirm documentation, controls and supply arrangements before routine manufacture.

REF. JV-GOV-005PROJECT GOVERNANCE

Defined responsibilities

The quality agreement and project plan should distinguish responsibilities for specifications, methods, materials, change control, deviations, release, regulatory communication and market supply.

Visible decision points

Technical decisions, assumptions, risks and approvals are documented so that both organizations understand what must happen before the next stage begins.

Confidentiality

Initial inquiries should avoid unnecessary confidential formulation details. Appropriate confidentiality arrangements can be established before detailed technical exchange.

Lifecycle support

Commercial manufacture requires ongoing review of changes, supply risks, performance trends and opportunities to improve reliability.

A project begins with fit

Share the product stage, dosage form and intended market.

Our team can review the available information and identify the most appropriate technical and commercial pathway.

Start a CMO / CDMO Inquiry